“…These vestibular side effects are more common in women than in men, occurring with a frequency of up to 7/10 (Fanning et al, 1977). Minocycline has other well-described peripheral and central side effects and because of multiple potential safety issues, the FDA added minocycline to its Adverse Event Reporting System (ARES) in 2009 effects (Balestrero et al, 2001;Cohen, 2004;Davies and Kersey, 1989;Fraser et al, 2012;Golstein et al, 1997;Gordon et al, 1995;Gough et al, 1996;Hanada et al, 2016;Hardman et al, 1996;Healy et al, 2009;Lander, 1989;Lefebvre et al, 2007;Matsuura et al, 1992;Porter and Harrison, 2003;Schlienger et al, 2000;van Steensel, 2004;Weller and Klockgether, 1998). That said, minocycline remains a mainstay drug for antibacterial therapy and has been taken safely and efficiently by millions of people.…”